Literature DB >> 11157687

Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes.

Y Sato1, T Yamada, R Taniguchi, K Nagai, T Makiyama, H Okada, K Kataoka, H Ito, A Matsumori, S Sasayama, Y Takatsu.   

Abstract

BACKGROUND: The measurement of serum concentrations of cardiac troponin T (TnT) is a simple, useful method to detect myocyte injury that may be repeated multiple times to follow patients without interobserver variability. METHODS AND
RESULTS: Multiple measurements of TnT with a second-generation assay were performed in 60 patients with dilated cardiomyopathy confirmed by coronary angiography and endomyocardial biopsy between April 1996 and December 1999. Three evolutionary patterns of TnT concentrations were identified. Thirty-three patients had concentrations of TnT <0.02 ng/mL throughout the follow-up period (group 1). The remaining 27 patients had high initial serum concentrations of TnT (>/=0.02 ng/mL). In 10 of these 27 patients, TnT decreased to <0.02 ng/mL during follow-up (group 2), whereas 17 had persistently high serum TnT concentrations despite being conventionally treated for chronic congestive heart failure (group 3). Although the initial echocardiographic left ventricular diastolic dimension (LVDd) and left ventricular ejection fraction (LVEF) were not significantly different among the 3 groups, follow-up echocardiography showed significantly decreased LVDd and increased LVEF in group 1 (each P:<0.01) and group 2 (each P:<0.05) compared with increased LVDd and decreased LVEF in group 3 (each P:<0.05). The cardiac event-free rate was significantly lower in group 3 than in groups 1 and 2 (each P:<0.001), and the survival rate was lower in group 3 than in group 1 (P:<0.05).
CONCLUSIONS: Persistently increased TnT concentrations in dilated cardiomyopathy suggest ongoing subclinical myocyte degeneration associated with deterioration of the patients' clinical status.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157687     DOI: 10.1161/01.cir.103.3.369

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  51 in total

1.  Serum cardiac troponin T and plasma brain natriuretic peptide in patients with cardiac decompensation.

Authors:  Y Sato; R Taniguchi; T Makiyama; K Nagai; H Okada; T Yamada; A Matsumori; Y Takatsu
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

2.  Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study.

Authors:  Sunil K Agarwal; Christy L Avery; Christie M Ballantyne; Diane Catellier; Vijay Nambi; Justin Saunders; A Richey Sharrett; Josef Coresh; Gerardo Heiss; Ron C Hoogeveen
Journal:  Clin Chem       Date:  2011-04-25       Impact factor: 8.327

3.  Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy.

Authors:  Y Sato; R Taniguchi; K Nagai; T Makiyama; H Okada; T Yamada; A Matsumori; Y Takatsu
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

4.  Serum values of cardiac troponin-T in normal and cardiomyopathic dogs.

Authors:  A Tarducci; O Abate; M Borgarelli; A Borrelli; R Zanatta; A Cagnasso
Journal:  Vet Res Commun       Date:  2004-08       Impact factor: 2.459

5.  Cardiac troponins.

Authors:  S Sharma; P G Jackson; J Makan
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

Review 6.  An update on cardiac troponins as circulating biomarkers in heart failure.

Authors:  Serge Masson; Roberto Latini; Inder S Anand
Journal:  Curr Heart Fail Rep       Date:  2010-03

7.  Biological variation of high sensitive Troponin T in stable heart failure patients with ischemic or dilated cardiomyopathy.

Authors:  Lutz Frankenstein; Andrew Remppis; Evangelos Giannitis; Joerdis Frankenstein; Georg Hess; Dietmar Zdunek; Andreas Doesch; Christian Zugck; Hugo A Katus
Journal:  Clin Res Cardiol       Date:  2011-02-17       Impact factor: 5.460

8.  Troponin I levels in a hemolytic uremic syndrome patient with severe cardiac failure.

Authors:  Varvara Askiti; Kristine Hendrickson; Alfred J Fish; Elizabeth Braunlin; Alan R Sinaiko
Journal:  Pediatr Nephrol       Date:  2003-12-18       Impact factor: 3.714

Review 9.  Biomarkers in heart failure: a clinical review.

Authors:  J Paul Rocchiccioli; John J V McMurray; Anna F Dominiczak
Journal:  Heart Fail Rev       Date:  2008-12-03       Impact factor: 4.214

10.  Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.

Authors:  Lori B Daniels; Gail A Laughlin; Paul Clopton; Alan S Maisel; Elizabeth Barrett-Connor
Journal:  J Am Coll Cardiol       Date:  2008-08-05       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.